Amit Garg
•
I have been in Silicon Valley for 20 years -- at Samsung NEXT Ventures, running my own startup (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures, and doing product and analytics at Google. My academic training is BS in computer science and MS in biomedical informatics, both from Stanford, and MBA from Harvard. I speak natively 3 languages, live carbon-neutral, am a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.
183 Stories by Amit Garg
Okay, so “pesky” was perhaps clickbait with some truth to it, but it’s undeniable that the fundraising process is inefficient. Some entrepreneurs seem to...
We started Tau Ventures in 2019 with the fundamental premise that the inflection point of AI was near. Specifically our thesis was predicated on the quadrant...
Principle 1: Why Bother With Venture Capital? Of the top 10 companies by market cap, 8 were funded by venture capital (and they all...
Excited to announce our investment in the seed for Transcera, a biotech company developing a ceramide lipid-based drug delivery platform that utilizes active transport pathways to increase...
We started Tau in 2019 with the fundamental premise that the inflection point of AI was near. Specifically our thesis was predicated on the...
Excited to announce our investment in the $9M series A for Blueprint Health, which helps mental health providers deliver effective treatment, more here. The...
How to divide equity among cofounders and employees is a perennial question in startup world. This article builds on Startup101: How Do I Divide Equity...
Excited to announce investment in the $18M series B of Sami Saúde alongside Redpoint eVentures, Monashees and Valor. Sami is focused on providing better healthcare insurance, starting with...
Excited to announce our investment in a $3.2M seed for Somethings, which provides mental health mentorship for teens. We are joined by General Catalyst,...
At Tau and repeatedly over my career, as an operator, entrepreneur and investor, I have been extolled the virtues of first-mover advantage. And my...
The nomenclature has got very muddled — why is a company raising a $10M called seed but another raising a $5M is series A?...
The nomenclature has got very muddled — why is a company raising a $10M called seed but another raising a $5M is series A?...
